SHANGHAI (Reuters) - Changsheng Bio-technology Co Ltd, a vaccine maker at the centre of a safety scandal in China, began falsifying production records for its rabies vaccine in April 2014, state news agency Xinhua reported on Tuesday.
Changsheng had mixed some batches with expired solution and did not correctly record dates or batch numbers, Xinhua said, citing the findings of an investigation team established by China's State Council.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!